Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Post by DavidRosenbergon Mar 09, 2023 11:00pm
90 Views
Post# 35329752

Brain spinal cord and neurons

Brain spinal cord and neurons
Yes, you are correct. Neurodegenerative disorders such as ALS (Amyotrophic Lateral Sclerosis), Parkinson's disease, multiple sclerosis, and others are characterized by the progressive degeneration and death of nerve cells in the brain and/or spinal cord.
 
One of the common features of these disorders is the degradation of the myelin sheath that surrounds and protects nerve fibers. The myelin sheath is a fatty, insulating layer that allows nerve impulses to travel quickly and efficiently along the nerve fibers.
 
In ALS, the myelin sheath around the nerve fibers that control muscle movement is gradually destroyed, leading to muscle weakness, stiffness, and eventually paralysis.
 
In Parkinson's disease, the myelin sheath in the brain that surrounds the nerve fibers that produce the neurotransmitter dopamine is damaged, leading to the characteristic motor symptoms of tremors, rigidity, and slowness of movement.
 
In multiple sclerosis, the immune system attacks and damages the myelin sheath in the brain and/or spinal cord, leading to a wide range of neurological symptoms such as muscle weakness, numbness, and difficulty with balance and coordination.
 
Overall, the degradation of the myelin sheath in these neurodegenerative disorders is thought to play a key role in the progressive loss of nerve function and the development of symptoms.
<< Previous
Bullboard Posts
Next >>